Literature DB >> 11304672

Surface grafting onto template-assembled synthetic protein scaffolds in molecular recognition.

J Fernandez-Carneado1, D Grell, P Durieux, J Hauert, T Kovacsovics, G Tuchscherer.   

Abstract

Creating functional biological molecules de novo requires a detailed understanding of the intimate relationship between primary sequence, folding mechanism, and packing topology, and remains up to now a most challenging goal in protein design and mimicry. As a consequence, the use of well-defined robust macromolecules as scaffolds for the introduction of function by grafting surface residues has become a major objective in protein engineering and de novo design. In this article, the concept of scaffolds is demonstrated on some selected examples, illustrating that novel types of functional molecules can be generated. Reengineered proteins and, most notably, de novo designed peptide scaffolds exhibiting molecular function, are ideal tools for structure-function studies and as leads in drug design. Copyright 2001 John Wiley & Sons, Inc. Biopolymers (Pept Sci) 55: 451-458, 2000

Mesh:

Substances:

Year:  2000        PMID: 11304672     DOI: 10.1002/1097-0282(2000)55:6<451::AID-BIP1020>3.0.CO;2-1

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  3 in total

1.  Protein grafting of an HIV-1-inhibiting epitope.

Authors:  Samuel K Sia; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

2.  Elicitation of structure-specific antibodies by epitope scaffolds.

Authors:  Gilad Ofek; F Javier Guenaga; William R Schief; Jeff Skinner; David Baker; Richard Wyatt; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

3.  A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.

Authors:  Xiaoman Li; Wei Xu; Sidong Xiong
Journal:  Clin Vaccine Immunol       Date:  2012-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.